

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 25mg | 180 pills | NZ$7.23 | NZ$1,735.10 NZ$1,301.32 Best Price | |
| 25mg | 120 pills | NZ$7.35 | NZ$1,176.00 NZ$882.00 | |
| 25mg | 90 pills | NZ$7.47 | NZ$896.45 NZ$672.34 | |
| 25mg | 60 pills | NZ$7.59 | NZ$607.26 NZ$455.45 | |
| 25mg | 30 pills | NZ$7.95 | NZ$318.07 NZ$238.56 | |
| 50mg | 180 pills | NZ$9.64 | NZ$2,313.47 NZ$1,735.10 Popular | |
| 50mg | 120 pills | NZ$9.76 | NZ$1,561.58 NZ$1,171.19 | |
| 50mg | 90 pills | NZ$9.88 | NZ$1,185.64 NZ$889.23 | |
| 50mg | 60 pills | NZ$10.00 | NZ$800.06 NZ$600.04 | |
| 50mg | 30 pills | NZ$10.12 | NZ$404.83 NZ$303.62 |
Could a single pill help your heart work more smoothly?
Inspra is the brand name for eplerenone. It belongs to a class of medicines called mineralocorticoid receptor antagonists. This means it blocks a hormone signal that can cause your body to hold onto water and potassium.
Inspra is used to support people with certain heart conditions and high blood pressure. It is part of a broader treatment plan that also includes diet, exercise, and other medicines. In New Zealand, you may need a prescription to obtain Inspra. Your clinician will decide if it is right for you based on your tests and symptoms.
Because Inspra affects potassium and kidney function, your healthcare team will check you regularly. They may adjust the dose if your kidneys are not working well or if your potassium level is too high or too low. If you notice unusual symptoms, tell them promptly.
Certain medicines and health conditions can change how Inspra works. Always tell your doctor about all medicines you take, including supplements and herbal products. This helps reduce the risk of interactions or side effects.
Inspra is approved to help manage heart failure with reduced heart pumping function. This means the heart does not squeeze as well as it should.
It is used alongside standard heart failure treatments to lower the risk of hospitalization and cardiovascular death in some patients. The exact benefit depends on your health picture and other medicines you take.
Inspra may also be prescribed for high blood pressure in some cases. It is not a first-choice medicine for everyone with high blood pressure. Your doctor will decide if it is suitable for you based on your overall risk profile and kidney function.
Inspra is sometimes added after a heart attack if you have signs of heart failure or reduced heart function. This helps support your heart as you recover and stabilise. The decision depends on your medical history and test results.
Your clinician will explain how Inspra fits with your other therapies. It is not meant to replace lifestyle changes or other prescribed medications. Regular follow-up will help ensure the treatment remains appropriate for you.
Inspra blocks a hormone signal that can cause the body to retain salt and water. By reducing this signal, it can help lower fluid buildup and protect heart function.
In a more detailed sense, eplerenone selectively inhibits mineralocorticoid receptors. This reduces the effects of aldosterone, a hormone involved in salt balance, blood pressure, and heart structure over time.
For many people, this means less swelling, steadier blood pressure, and reduced stress on the heart. The effect builds up as the medicine continues to be taken with the rest of your treatment plan.
Because the bodyβs salts and fluids change with your kidneys and diet, the exact response to Inspra can vary. Your doctor will monitor your response with tests and discussions about symptoms.
Inspra is designed to be more selective than older medicines in the same family. This can translate to fewer effects on some parts of the body, though it still requires careful monitoring. Your team will tailor advice to you personally.
Plain language: Inspra locks the action of a hormone that can cause the body to hold onto water. When water at the wrong times builds up, your heart works harder.
More detailed pharmacology: It binds to mineralocorticoid receptors with high selectivity, blocking aldosteroneβs signaling. This reduces sodium and water retention without strongly affecting other hormone systems.
The result is improved fluid balance and blood pressure control in many patients with heart conditions. The exact balance of benefits and risks depends on age, kidney function, and other medicines.
The medicine does not act immediately. It takes days to weeks to see meaningful changes in symptoms and test results. Consistency is important for the best outcome.
Because it changes electrolyte balance, Inspra requires monitoring. Your clinician may check potassium and kidney function with blood tests as you start and continue treatment. This helps catch any issues early.
Your clinician will determine the right starting point and any needed adjustments. They consider kidney function, potassium levels, other medicines, and your cardiovascular status. Do not change the dose yourself.
Take Inspra exactly as prescribed, with or without food, unless your doctor advises otherwise. Consistency helps your body respond predictably. If you miss a dose, contact your clinician for guidance rather than doubling up.
Inform all healthcare providers that you are taking Inspra. This includes dentists, specialists, and pharmacists. Some procedures or medicines may require adjustments or temporary changes.
Routine monitoring is common. You may have blood tests to check potassium and kidney function. Your doctor may also review blood pressure and heart symptoms during clinic visits.
Certain situations require extra caution. If you have kidney disease, dehydration, or are taking potassium supplements or other potassium-sparing medicines, your doctor may adjust the plan. This helps prevent high potassium levels or kidney stress.
Inspra can be safe and helpful when used correctly, but it has potential risks. The most important issue is potassium balance. High potassium levels can be serious and require medical attention.
Do not take Inspra if you have severe kidney impairment or very high potassium unless your clinician specifically advises otherwise and provides close supervision. Your doctor will weigh benefits and risks carefully in such cases.
Tell your doctor if you have any of these conditions: kidney problems, liver problems, or a history of high potassium. Also share if you have recently started a new medicine or supplement that could affect potassium.
Pregnancy and breastfeeding require careful planning with your health team. The safety of Inspra in pregnancy or while nursing is a decision that your clinician must make based on your situation.
Common side effects may include dizziness, high potassium symptoms, or stomach upset. Seek urgent medical help if you notice symptoms like severe muscle weakness, confusion, or trouble breathing.
Your care team will consider your local guidelines and available monitoring options. In NZ, routine checks and follow-ups help ensure Inspra remains appropriate for you. The treatment plan often includes lifestyle advice and supportive therapies alongside medicine.
Drug interactions are important to manage. Some medicines raise potassium or affect kidney function. Always inform your pharmacist about all medicines, including over-the-counter products and natural therapies.
Access and prescription processes vary by region and clinic. If you have questions about eligibility or how to obtain Inspra, ask your clinician or pharmacist for guidance. They can outline the steps in your area.
Emergency or urgent symptoms require prompt medical evaluation. If you experience severe swelling, chest pain, fainting, or signs of dangerously high potassium, seek urgent medical help.
| Drug | Typical indications | Key considerations |
|---|---|---|
| Inspra (eplerenone) | Heart failure with reduced ejection fraction; sometimes hypertension; post-MI care as part of broader therapy | Selective mineralocorticoid receptor antagonist; monitoring for potassium and kidney function; fewer hormonal side effects than some older agents |
| Spironolactone | Heart failure; resistant hypertension; edema due to liver or kidney disease | Non-selective MR antagonist; may cause hormonal side effects; requires similar monitoring for potassium and kidney function |
| Finerenone | Diabetes-related kidney disease with risk of progression; some off-label uses in other kidney conditions | Newer, more selective MR antagonist; different pharmacology; monitoring remains important |
High potassium should be corrected first. Your clinician will check your levels before starting Inspra and monitor them closely after you begin treatment.
If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not double up. Contact your clinician for personalised advice if you are unsure what to do.
Moderate alcohol is usually fine for many people, but it can affect blood pressure and hydration. Discuss your drinking with your clinician, especially if you notice dizziness or fainting.
A balanced diet is best. Some foods can influence potassium levels. Your clinician may suggest avoiding very high-potassium foods if you have elevated potassium or kidney concerns.
Some people notice changes in symptoms within a few weeks, others over several weeks. Your blood tests provide important information about how the medicine is working.
Inspra can be used long term when it is safe and effective. Your doctor will regularly review your treatment to adjust as needed and to protect your kidneys and potassium balance.
Do not stop suddenly without discussing with your clinician. Some side effects may require dose adjustments or alternative therapies.
Pregnancy involves special considerations. Your clinician will discuss risks and alternatives if you are pregnant or planning pregnancy.
You may have blood tests to check potassium and kidney function, and blood pressure readings at follow-up visits. Your doctor will decide the testing schedule for you.
Yes, interactions are possible. Inform your pharmacist about all medicines you take, including non-prescription products and supplements. Your clinician may adjust treatment if needed.
Lightheadedness or fainting can occur, especially after standing up. Sit or lie down and contact your clinician if the symptoms persist or worsen.
Seek urgent medical help if you have severe swelling, chest pain, trouble breathing, or signs of very high potassium such as muscle weakness with confusion. Do not delay care.
Many people take Inspra alongside other heart medicines. Your doctor will check for potential interactions and adjust doses as needed to keep you safe.
The duration depends on your condition and response to treatment. Regular review with your clinician will guide decisions about continuing or adjusting therapy.
Yes, Inspra can lower blood pressure in some people. Your clinician will monitor your readings to ensure they stay in a safe range while avoiding dizziness or fainting.
Tell your surgeon or dentist you are taking Inspra. They may advise on temporary changes or monitoring during procedures or anesthesia.
Switching should only occur under medical advice. Your clinician will consider your symptoms, potassium, kidney function, and other medications before changing therapy.
Eplerenone is the generic name for Inspra. Availability can vary by country and pharmacy. Your clinician or pharmacist can confirm current options in New Zealand.
14β21 days. Free from NZ$347.25 .
5β9 days. NZ$52.09
β10% when paying with cryptocurrency.
β10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
